Skip to main content

Table 1 The number of innate lymphoid cells (ILCs) among three groups

From: Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function

 

Normal control

(N = 25)

HUA before GGQLD

(N = 30)

HUA after GGQLD

(N = 30)

P-value

ILC

1.265 ± 0.885

7.243 ± 3.594

2.523 ± 1.245

 < 0.0001*

ILC1

41.972 ± 32.606

37.943 ± 36.289

49.895 ± 25.103

0.3361

ILC2

26.226 ± 17.918

23.957 ± 22.081

35.900 ± 24.283

0.0877

ILC3

31.802 ± 24.460

38.100 ± 39.037

14.205 ± 12.618

0.0040*

ILC1/ILC2

132.668 ± 648.069

5.078 ± 11.081

3.698 ± 6.146

0.3122

ILC3/ILC2

5.806 ± 17.946

33.584 ± 68.674

0.743 ± 0.991

0.0072*

  1. *P ≤ 0.05